Literature DB >> 7844073

Epidemiology of neonatal infections.

M J Tarlow1.   

Abstract

Neonatal infections can be considered in three groups, those acquired antenatally, perinatally and nosocomially. For many years it has been recognized that antenatal infections may cause death or serious fetal damage, but only recently have the more subtle features of antenatal infection been recognized. These include particularly the ability of some (such as toxoplasmosis) to produce disease many years later. Perinatal infection is often the result of maternal carriage of organisms, usually asymptomatically, and a variety of treatment approaches including immunotherapy (for hepatitis B) and antibacterial prophylaxis (for chlamydia) are being used to reduce the short- and long-term morbidity associated with this route of neonatal infection. Nosocomial infection in the neonatal nursery, and particularly in the neonatal intensive care unit may again lead to longer term problems in the infant, and organisms such as staphylococci or salmonella acquired during neonatal life may cause invasive disease weeks or even months later. The prevention of nosocomial infection will depend on the synthesis of a variety of approaches to reduce the number and spread of organisms in the environment of the vulnerable neonate.

Entities:  

Mesh:

Year:  1994        PMID: 7844073     DOI: 10.1093/jac/34.suppl_a.43

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  2 in total

1.  Urine sample used for congenital toxoplasmosis diagnosis by PCR.

Authors:  I Fuentes; M Rodriguez; C J Domingo; F del Castillo; T Juncosa; J Alvar
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

2.  Clinical algorithms for the screening of pregnant women for STDs in Libreville, Gabon: which alternatives?

Authors:  A Bourgeois; D Henzel; G Malonga-Mouelet; G Dibanga; C Tsobou; M Peeters; E Delaporte
Journal:  Sex Transm Infect       Date:  1998-02       Impact factor: 3.519

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.